OTLK · Categories · Form 4

OTLK - SEC Form 4 insider transactions

Outlook Therapeutics Inc. (OTLK) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for OTLK

• 249d
  SEC Form 4 filed by Director Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 249d
  SEC Form 4 filed by Director Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 249d
  SEC Form 4 filed by Director Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 249d
  SEC Form 4 filed by Director Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 249d
  SEC Form 4 filed by Director Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 249d
  SEC Form 4 filed by Director Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 249d
  SEC Form 4 filed by Director Thurman Randy H

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 249d
  SEC Form 4 filed by Director Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 335d
  SEC Form 4 filed by Chief Executive Officer Jahr Robert Charles

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 377d
  Director Sukhtian Ghiath M. was granted 4,285,714 shares (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 454d
  Amendment: Director Sukhtian Ghiath M. exercised 3,458,571 shares at a strike of $2.51 (SEC Form 4)

  4/A - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 488d
  SEC Form 4 filed by Director Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 503d
  SEC Form 4 filed by Director Sukhtian Ghiath M.

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 614d
  SEC Form 4 filed by Director Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 614d
  SEC Form 4 filed by Director Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 614d
  SEC Form 4 filed by Director Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 614d
  SEC Form 4 filed by Director Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 614d
  SEC Form 4 filed by Director Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 614d
  SEC Form 4 filed by Director Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 614d
  SEC Form 4 filed by Director Thurman Randy H

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 614d
  SEC Form 4 filed by Director Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 809d
  SEC Form 4 filed by Kenyon Lawrence A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 809d
  SEC Form 4 filed by Evanson Jeff

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 809d
  SEC Form 4 filed by Trenary C Russell Iii

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 811d
  Sukhtian Ghiath M. was granted 2,305,714 shares (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 823d
  SEC Form 4 filed by Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 823d
  SEC Form 4 filed by Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 823d
  SEC Form 4 filed by Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 823d
  SEC Form 4 filed by Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 823d
  SEC Form 4 filed by Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 823d
  SEC Form 4 filed by Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 823d
  SEC Form 4 filed by Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 823d
  SEC Form 4 filed by Thurman Randy H

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 978d
  SEC Form 4 filed by Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 978d
  SEC Form 4 filed by Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 978d
  SEC Form 4 filed by Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 978d
  SEC Form 4 filed by Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 978d
  SEC Form 4 filed by Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 978d
  SEC Form 4 filed by Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 978d
  SEC Form 4 filed by Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1145d
  SEC Form 4 filed by Dagnon Terry

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1147d
  SEC Form 4 filed by Dagnon Terry

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1147d
  SEC Form 4 filed by Evanson Jeff

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1147d
  SEC Form 4 filed by Trenary C Russell Iii

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1166d
  SEC Form 4 filed by Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1166d
  SEC Form 4 filed by Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1166d
  SEC Form 4 filed by Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1166d
  SEC Form 4 filed by Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1166d
  SEC Form 4 filed by Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1166d
  SEC Form 4 filed by Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1166d
  SEC Form 4 filed by Thurman Randy H

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1166d
  SEC Form 4 filed by Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1232d
  SEC Form 4: Evanson Jeff sold $296,370 worth of shares (267,000 units at $1.11), decreasing direct ownership by 26% to 745,975 units

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1237d
  SEC Form 4: Evanson Jeff sold $203,726 worth of shares (164,155 units at $1.24), decreasing direct ownership by 14% to 1,012,975 units

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1258d
  SEC Form 4: Sukhtian Ghiath M. was granted 14,230,418 shares

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1337d
  SEC Form 4: Sukhtian Faisal Ghiath bought $38,700 worth of shares (30,000 units at $1.29), increasing direct ownership by 79% to 68,000 units

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1337d
  SEC Form 4: Haddadin Yezan Munther bought $42,940 worth of shares (33,343 units at $1.29), increasing direct ownership by 111% to 63,343 units

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1341d
  SEC Form 4 filed by Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1341d
  SEC Form 4 filed by Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1341d
  SEC Form 4 filed by Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)

Other OTLK categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends